Pharvaris N.V. (PHVS)
NASDAQ·Healthcare·Biotechnology
$30.96
-3.85%
Mkt Cap $2.20B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (12 analysts)
$43.67
Range $38.00 – $52.00
Implied Upside
+41.1%
Consensus $43.67 vs current $30.96
NASDAQ·Healthcare·Biotechnology
$30.96
-3.85%
Mkt Cap $2.20B
Buy
3
Hold
0
Sell
0
Price Target (12 analysts)
$43.67
Range $38.00 – $52.00
+41.1%
Consensus $43.67 vs current $30.96